Maxion Therapeutics

Maxion® Therapeutics | Home

Cambridge, United Kingdom · Founded 2020 · $88.0M raised

Headquarters
Cambridge
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$88.0M
Last Round
$72.0M Series AMar 2025
Rounds
2

About

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat autoimmune, pain, and cardiovascular diseases.

Summary

Maxion Therapeutics is a Life Sciences company based in Cambridge, United Kingdom, founded in 2020. It has raised $88.0M in total across 2 rounds, most recently a $72.0M Series A round in Mar 2025. Investors include LifeArc, Monograph Capital and BGF.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AMar 2025
$72.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Maxion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/maxion-therapeutics"><img src="https://indexed.vc/api/badge/company/maxion-therapeutics" alt="Maxion Therapeutics on Indexed.vc" width="260" height="76" /></a>